Table 1. Study design to investigate CWD vertical/maternal transmission.
Offspring cohort | Dam’s CWD status | Dam # | Offspring # | Dam’s clinical disease stage (cohort) | Offspring gestational stage |
Full term viable | Positive | 11* | 242 | Late (2) | Full term |
45 | 531 | Late (2) | Full term | ||
46 | 551 | Early (1) | Full term | ||
Negative | 16 | 201 | NCD (3) | Full term | |
16 | 222 | NCD (3) | Full term | ||
19 | 211 | NCD (3) | Full term | ||
19 | 262 | NCD (3) | Full term | ||
Full term nonviable | Positive | 11* | 231 | Early (1) | Full term |
50 | 541 | Early (1) | Full term | ||
15 | 251 | Late (2) | Full term | ||
47 | 511 | Late (2) | Full term | ||
44 | 521 | Late (2) | Full term died 10 dpb | ||
43 | 561 | Late (2) | Full term died 2 dpb | ||
Negative | 16 | 273 | NCD (3) | Full term died 5 dpb | |
In utero harvest | Positive | 47 | 572 | Late (2) | Late gestation |
45 | 582 | Late (2) | Late gestation | ||
50 | 592 | Late (2) | Early gestation | ||
Negative | 64 | 801 | NCD (3) | Early gestation |
Dam inoculated orally (PO) only. All other dams inoculated PO and subcutaneously (SC).
Late = > ½ time to dam terminal TSE disease.
Early = < ½ time to dam terminal TSE disease.
Late gestation = >3.5 months gestation.
Early gestation = <3.5 months gestation.
NCD = No clinical disease.
dpb = days post birth.
Dam’s first conception.
Dam’s second conception.
Dam’s third conception.